Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jun;118(3):466-70.
doi: 10.1111/j.1476-5381.1996.tb15426.x.

Relaxation of guinea-pig trachea by sodium nitroprusside: cyclic GMP and nitric oxide not involved

Affiliations

Relaxation of guinea-pig trachea by sodium nitroprusside: cyclic GMP and nitric oxide not involved

G Sadeghi-Hashjin et al. Br J Pharmacol. 1996 Jun.

Abstract

1. Sodium nitroprusside (SNP) completely relaxed the guinea-pig isolated, perfused trachea in a concentration-dependent manner. Although SNP was less potent by about 2 orders of magnitude, its maximal effect was 25% higher compared to isoprenaline. 2. SNP (3.2 microM) increased cyclic GMP levels by 300% and relaxed guinea-pig isolated, perfused trachea by 54%. The SNP-induced relaxations of the preparations were not affected by the guanylate cyclase inhibitor, methylene blue. Moreover, zaprinast, a cyclic GMP-specific phosphodiesterase inhibitor which was supposed to enhance SNP-induced relaxations, decreased the maximal relaxation by 22% (P < 0.001). 3. In contrast, 8Br-cyclic GMP (10 microM) increased the cyclic GMP levels by 1100% without inducing a marked relaxation. 4. SNP (10 microM) and S-nitroso-N-acetylpenicillamine (SNAP; a direct donor of nitric oxide; 10 microM), relaxed the tissues by 75% and 25%, respectively, without any nitric oxide (NO) release by SNP (< 1 pmol 100 microliters-1), but a substantial NO release by SNAP (560 pmol 100 microliters-1). 5. It is concluded that the SNP-induced tracheal relaxations are probably not mediated by cyclic GMP and NO.

PubMed Disclaimer

References

    1. Mol Pharmacol. 1977 Mar;13(2):330-41 - PubMed
    1. J Pharmacol Exp Ther. 1995 Mar;272(3):1141-50 - PubMed
    1. Adv Cyclic Nucleotide Res. 1978;9:145-58 - PubMed
    1. FEBS Lett. 1980 Feb 11;110(2):275-8 - PubMed
    1. Acta Pharmacol Toxicol (Copenh). 1982 May;50(5):350-7 - PubMed

LinkOut - more resources